Related references
Note: Only part of the references are listed.Prospective external validation of biomarkers to predict acute graft-versus-host disease severity
Marie Robin et al.
BLOOD ADVANCES (2022)
Post-haematopoietic cell transplantation outcomes: why ST2 became a 'golden nugget' biomarker
Sophie Paczesny
BRITISH JOURNAL OF HAEMATOLOGY (2021)
MRD Tailored Therapy in AML: What We Have Learned So Far
Lok Lam Ngai et al.
FRONTIERS IN ONCOLOGY (2021)
Elevation of Early Plasma Biomarkers in Patients with Clinical Risk Factors Predicts Increased Nonrelapse Mortality after Allogeneic Hematopoietic Stem Cell Transplantation
Masaaki Hotta et al.
TRANSPLANTATION AND CELLULAR THERAPY (2021)
Assessment of ST2 for risk of death following graft-versus-host disease in pediatric and adult age groups
Courtney M. Rowan et al.
BLOOD (2020)
Disease risk and GVHD biomarkers can stratify patients for risk of relapse and nonrelapse mortality post hematopoietic cell transplant
Mina D. Aziz et al.
LEUKEMIA (2020)
Stabilization patterns and variability of hs-CRP, NT-proBNP and ST2 during 1 year after acute coronary syndrome admission: results of the BIOMArCS study
Victor J. van den Berg et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2020)
Calculating the sample size required for developing a clinical prediction model
Richard D. Riley et al.
BMJ-BRITISH MEDICAL JOURNAL (2020)
Biomarkers for Allogeneic HCT Outcomes
Djamilatou Adom et al.
FRONTIERS IN IMMUNOLOGY (2020)
Soluble ST2: A complex and diverse role in several diseases
Evgenija Homsak et al.
CLINICA CHIMICA ACTA (2020)
ST2 and REG3α as Predictive Biomarkers After Haploidentical Stem Cell Transplantation Using Post-transplantation High-Dose Cyclophosphamide
Laura Solan et al.
FRONTIERS IN IMMUNOLOGY (2019)
The MAGIC algorithm probability is a validated response biomarker of treatment of acute graft-versus-host disease
Hrishikesh K. Srinagesh et al.
BLOOD ADVANCES (2019)
MAGIC biomarkers predict long-term outcomes for steroid-resistant acute GVHD
Hannah Major-Monfried et al.
BLOOD (2018)
Plasma biomarkers of risk for death in a multicenter phase 3 trial with uniform transplant characteristics post-allogeneic HCT
Mohammad Abu Zaid et al.
BLOOD (2017)
Changes in protein serum levels during stem cell transplantation
Elisabetta Metafuni et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2017)
Plasma-derived proteomic biomarkers in human leukocyte antigen-haploidentical or human leukocyte antigen-matched bone marrow transplantation using post-transplantation cyclophosphamide
Christopher G. Kanakry et al.
HAEMATOLOGICA (2017)
ST2 and Endothelial Injury as a Link between GVHD and Microangiopathy
Seth J. Rotz et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Associations between acute GVHD-related biomarkers and endothelial cell activation after allogeneic hematopoietic stem cell transplantation
Shosaku Nomura et al.
TRANSPLANT IMMUNOLOGY (2017)
Plasma-derived proteomic biomarkers in human leukocyte antigen-haploidentical or human leukocyte antigen-matched bone marrow transplantation using post-transplantation cyclophosphamide
Christopher G. Kanakry et al.
HAEMATOLOGICA (2017)
The ST2/IL-33 Axis in immune Cells during inflammatory Diseases
Brad Griesenauer et al.
FRONTIERS IN IMMUNOLOGY (2017)
Prognostic Scoring Systems in Allogeneic Hematopoietic Stem Cell Transplantation: Where Do We Stand?
Rashmika Potdar et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2017)
Metabolic Complications Precede Alloreactivity and Are Characterized by Changes in Suppression of Tumorigenicity 2 Signaling
Romany A. N. Johnpulle et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2017)
An early-biomarker algorithm predicts lethal graft-versus-host disease and survival
Matthew J. Hartwell et al.
JCI INSIGHT (2017)
Baseline body mass index among children and adults undergoing allogeneic hematopoietic cell transplantation: clinical characteristics and outcomes
M. Gleimer et al.
BONE MARROW TRANSPLANTATION (2015)
Prognostic Biomarkers for Acute Graft-versus-Host Disease Risk after Cyclophosphamide-Fludarabine Nonmyeloablative Allotransplantation
Robert P. Nelson et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2014)
ST2 as a Marker for Risk of Therapy-Resistant Graft-versus-Host Disease and Death
Mark T. Vander Lugt et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Assessing the Performance of Prediction Models A Framework for Traditional and Novel Measures
Ewout W. Steyerberg et al.
EPIDEMIOLOGY (2010)
Graft-versus-host disease
James L. M. Ferrara et al.
LANCET (2009)
Use and misuse of the receiver operating characteristic curve in risk prediction
Nancy R. Cook
CIRCULATION (2007)
Statistics notes - The cost of dichotomising continuous variables
DG Altman et al.
BRITISH MEDICAL JOURNAL (2006)
Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT
ML Sorror et al.
BLOOD (2005)
Internal validation of predictive models: Efficiency of some procedures for logistic regression analysis
EW Steyerberg et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2001)